CN1612691A - 纠正心脏传导障碍的方法和组合物 - Google Patents

纠正心脏传导障碍的方法和组合物 Download PDF

Info

Publication number
CN1612691A
CN1612691A CNA028269055A CN02826905A CN1612691A CN 1612691 A CN1612691 A CN 1612691A CN A028269055 A CNA028269055 A CN A028269055A CN 02826905 A CN02826905 A CN 02826905A CN 1612691 A CN1612691 A CN 1612691A
Authority
CN
China
Prior art keywords
cell
cells
recombinant
muscle cell
skeletal muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028269055A
Other languages
English (en)
Chinese (zh)
Inventor
R·J·李
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of CN1612691A publication Critical patent/CN1612691A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
CNA028269055A 2001-11-08 2002-11-07 纠正心脏传导障碍的方法和组合物 Pending CN1612691A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33735201P 2001-11-08 2001-11-08
US60/337,352 2001-11-08

Publications (1)

Publication Number Publication Date
CN1612691A true CN1612691A (zh) 2005-05-04

Family

ID=23320214

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028269055A Pending CN1612691A (zh) 2001-11-08 2002-11-07 纠正心脏传导障碍的方法和组合物

Country Status (10)

Country Link
US (2) US7252819B2 (enExample)
EP (1) EP1453382A4 (enExample)
JP (1) JP2005527482A (enExample)
CN (1) CN1612691A (enExample)
AU (1) AU2002359371A1 (enExample)
BR (1) BR0214018A (enExample)
CA (1) CA2465476A1 (enExample)
IL (1) IL161862A0 (enExample)
MX (1) MXPA04004396A (enExample)
WO (1) WO2003039344A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111107880A (zh) * 2017-09-20 2020-05-05 加利福尼亚大学董事会 用于恢复致心律失常性右室心肌病中的电性和心脏功能以及心脏结构的基因疗法策略
US12098385B2 (en) 2017-09-20 2024-09-24 The Regents Of The University Of California Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359371A1 (en) 2001-11-08 2003-05-19 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
US20060002898A1 (en) * 2002-05-08 2006-01-05 Lee Randall J Methods and compositions for correction of cardiac conduction disturbances
JP2005538945A (ja) * 2002-05-08 2005-12-22 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 心不整脈を線維芽細胞で治療するためのシステム及び方法
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7627373B2 (en) 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7794702B2 (en) * 2003-01-15 2010-09-14 The Trustees Of Columbia University In The City Of New York Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
EP1691747B1 (en) * 2003-11-13 2012-05-23 CardioPolymers, Inc. Control of cardiac arrhythmias by modification of neuronal conduction within fat pads of the heart
US8073538B2 (en) * 2003-11-13 2011-12-06 Cardio Polymers, Inc. Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
US20060128647A1 (en) * 2003-12-24 2006-06-15 Daniel Sigg Novel oligonucleotides and treating cardiac disorders by using the same
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US20080260705A1 (en) * 2004-03-22 2008-10-23 The Johns Hopkins University Preventing Arrhythmias Associated with Cell Transplantation
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US20050277124A1 (en) * 2004-06-10 2005-12-15 White Steven M Cardiac conduction system cells and uses thereof
US20050283218A1 (en) * 2004-06-22 2005-12-22 Williams Michael S Implantable chamber for biological induction or enhancement of muscle contraction
WO2006044589A2 (en) * 2004-10-13 2006-04-27 Medtronic, Inc. Cellular and genetic intervention to treat ventricular tachycardia
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
WO2007147014A2 (en) * 2006-06-13 2007-12-21 Fmc Biopolymer As Method and systems for using biopolymer-based beads and hydrogels
US9375313B2 (en) * 2006-09-08 2016-06-28 The Regents Of The University Of California Intramyocardial patterning for global cardiac resizing and reshaping
US7787949B2 (en) * 2006-10-30 2010-08-31 Medtronic, Inc. Biological pacemaker compositions and systems incorporating interstitial cells of Cajal
JP2010523264A (ja) * 2007-04-11 2010-07-15 ヘンリー フォード ヘルス システム 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008154033A2 (en) * 2007-06-11 2008-12-18 Symphony Medical, Inc. Cardiac patterning for improving diastolic function
EP2203129A4 (en) * 2007-10-15 2011-11-23 Univ Wake Forest Health Sciences METHOD AND COMPOSITIONS FOR PRINTING BIOCOMPATIBLE NANOROUS COMPOSITES FROM AUTOLOGOUS TISSUE
WO2009111755A2 (en) * 2008-03-07 2009-09-11 The Trustees Of Columbia University In The City Of New York Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein
CN106178118A (zh) 2008-09-30 2016-12-07 加利福尼亚大学董事会 用于组织修复的使用细胞外基质的组合物和方法
AU2010300611B2 (en) 2009-10-02 2015-12-10 Baxalta GmbH Hematopoietic stem cells for use in the treatment of a kidney injury
CN106619723A (zh) 2010-08-24 2017-05-10 加利福尼亚大学董事会 用于心脏治疗的组合物和方法
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2013036708A2 (en) 2011-09-07 2013-03-14 The Regents Of The University Of California Compositions and methods for tissue repair with extracellular matrices
JP2015508101A (ja) 2012-02-21 2015-03-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｃｄ３４＋細胞を含む薬学的組成物
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
WO2015120216A1 (en) 2014-02-07 2015-08-13 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms
CN106232800B (zh) 2014-03-25 2020-07-03 泰尔茂比司特公司 介质的被动替代
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP7705950B2 (ja) 2021-03-23 2025-07-10 テルモ ビーシーティー、インコーポレーテッド 細胞を増殖する方法
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5030204A (en) 1988-09-28 1991-07-09 Advanced Cardiovascular Systems, Inc. Guiding catheter with controllable distal tip
US5103821A (en) 1989-03-06 1992-04-14 Angeion Corporation Method of providing a biological pacemaker
WO1990010471A1 (en) 1989-03-06 1990-09-20 Angeion Corporation Method of providing a biological pacemaker
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5087243A (en) 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5661133B1 (en) 1991-11-12 1999-06-01 Univ Michigan Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5551426A (en) 1993-07-14 1996-09-03 Hummel; John D. Intracardiac ablation and mapping catheter
US5602301A (en) 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US5489294A (en) 1994-02-01 1996-02-06 Medtronic, Inc. Steroid eluting stitch-in chronic cardiac lead
CN1127343C (zh) 1994-12-13 2003-11-12 彼得·K·罗 治疗哺乳动物疾病的成肌细胞组合物
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5693029A (en) 1995-07-10 1997-12-02 World Medical Manufacturing Corporation Pro-cell intra-cavity therapeutic agent delivery device
US6415178B1 (en) 1996-09-16 2002-07-02 Impulse Dynamics N.V. Fencing of cardiac muscles
WO1998002150A1 (en) 1996-07-17 1998-01-22 Medtronic, Inc. System for genetically treating cardiac conduction disturbances
DE69626135T2 (de) 1996-09-10 2003-10-23 Omrix Biopharmaceuticals Sa, Rhode-St-Genese Vorrichtung zur applikation einer mehrkomponentenflüssigkeit
US5722403A (en) 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US6059726A (en) 1996-11-08 2000-05-09 The Regents Of The University Of California Method for locating the atrio-ventricular (AV) junction of the heart and injecting active substances therein
US6239117B1 (en) 1997-02-13 2001-05-29 Albert Einstein College Of Medicine Of Yeshiva University Gene therapy for regulating bladder smooth muscle tone
US6271211B1 (en) * 1997-02-13 2001-08-07 Albert Einstein College Of Medicine Of Yeshiva University Gene therapy for regulating penile smooth muscle tone
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
CA2285056C (en) 1997-04-03 2004-12-14 Iacob Mathiesen Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
US6238429B1 (en) 1997-05-05 2001-05-29 Medtronic, Inc. Biologic cabling
DE69831957T3 (de) 1997-07-14 2009-07-23 Osiris Therapeutics, Inc. Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
EP1015042A1 (en) 1997-09-19 2000-07-05 Reprogenesis, Inc Improved hydrogel for tissue engineering
US6151525A (en) 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
DE69838526T2 (de) 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Gerät zum Freisetzen eines Medikaments im Herzen
US6360749B1 (en) 1998-10-09 2002-03-26 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US20010009986A1 (en) 1999-02-23 2001-07-26 Cordis Webster, Inc. Steerable catheter for detecting and revascularizing ischemic myocardial tissue
CA2402000A1 (en) 2000-03-06 2001-09-13 Tei Biosciences, Inc. Injectable bio-compatible material and methods of use
AU2001243551A1 (en) 2000-03-10 2001-09-24 Indiana University Research & Technology Corporation Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
DE10021627B4 (de) 2000-05-04 2009-11-19 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Verfahren zur Herstellung eines vaskularisierten bioartifiziellen Gewebes und zugehöriger Versuchsreaktor
US20020001577A1 (en) * 2000-06-30 2002-01-03 Axel Haverich Use of cells with the ability to generate excitation within a cell preparation
WO2002009650A2 (en) 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
EP1324780A4 (en) 2000-09-06 2005-06-22 Univ Johns Hopkins METHODS OF TREATING CARDIAC ARRHYTHMIA
US7294333B1 (en) 2000-10-20 2007-11-13 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
AU2002359371A1 (en) 2001-11-08 2003-05-19 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
US6932804B2 (en) 2003-01-21 2005-08-23 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
JP2005538945A (ja) 2002-05-08 2005-12-22 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 心不整脈を線維芽細胞で治療するためのシステム及び方法
US20040106896A1 (en) 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20060002898A1 (en) 2002-05-08 2006-01-05 Lee Randall J Methods and compositions for correction of cardiac conduction disturbances
AU2003239418B2 (en) 2002-05-08 2008-01-31 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US7317950B2 (en) 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111107880A (zh) * 2017-09-20 2020-05-05 加利福尼亚大学董事会 用于恢复致心律失常性右室心肌病中的电性和心脏功能以及心脏结构的基因疗法策略
US12098385B2 (en) 2017-09-20 2024-09-24 The Regents Of The University Of California Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

Also Published As

Publication number Publication date
AU2002359371A1 (en) 2003-05-19
US20080019953A1 (en) 2008-01-24
JP2005527482A (ja) 2005-09-15
US7252819B2 (en) 2007-08-07
IL161862A0 (en) 2005-11-20
WO2003039344A2 (en) 2003-05-15
BR0214018A (pt) 2005-04-19
US7494644B2 (en) 2009-02-24
MXPA04004396A (es) 2004-08-11
WO2003039344A3 (en) 2003-12-31
US20030104568A1 (en) 2003-06-05
EP1453382A2 (en) 2004-09-08
CA2465476A1 (en) 2003-05-15
EP1453382A4 (en) 2005-05-18

Similar Documents

Publication Publication Date Title
CN1612691A (zh) 纠正心脏传导障碍的方法和组合物
US20080152635A1 (en) Methods and compositions for correction of cardiac conduction disturbances
JP4562816B2 (ja) 心筋再生のための間葉幹細胞の使用法および組成物
US8852570B2 (en) Cardiac muscle regeneration using mesenchymal stem cells
JP6162104B2 (ja) 細胞及び遺伝子に基づく心臓機能改善方法
JP2006506207A (ja) 心臓刺激用の装置および方法
US10905722B2 (en) Induced pacemaker and Purkinje cells from adult stem cells
EP2476751A1 (en) Cardiac muscle regeneration using mesenchymal stem cells
CN1533431A (zh) 细胞移植的方法和试剂
Rosen Biological pacemaking: In our lifetime?
WO2001068814A2 (en) Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
US20100047216A1 (en) Compositions of late passage mesenchymal stem cells (mscs)
US20100049273A1 (en) Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders
JP5674046B2 (ja) 新規ペースメーカ細胞
CN1703257A (zh) 心脏刺激系统和方法
US9506032B2 (en) Engineered biological pacemakers
Narazaki et al. Creations of biological Pacemaker
HK1261376A1 (en) Induced pacemaker and purkinje cells from adult stem cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication